1. Home
  2. ELTX vs BRLS Comparison

ELTX vs BRLS Comparison

Compare ELTX & BRLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • BRLS
  • Stock Information
  • Founded
  • ELTX 2011
  • BRLS 2019
  • Country
  • ELTX United States
  • BRLS Canada
  • Employees
  • ELTX N/A
  • BRLS N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • BRLS
  • Sector
  • ELTX Health Care
  • BRLS
  • Exchange
  • ELTX Nasdaq
  • BRLS NYSE
  • Market Cap
  • ELTX 121.7M
  • BRLS 130.4M
  • IPO Year
  • ELTX N/A
  • BRLS N/A
  • Fundamental
  • Price
  • ELTX $8.05
  • BRLS $4.75
  • Analyst Decision
  • ELTX Strong Buy
  • BRLS
  • Analyst Count
  • ELTX 2
  • BRLS 0
  • Target Price
  • ELTX $9.50
  • BRLS N/A
  • AVG Volume (30 Days)
  • ELTX 51.5K
  • BRLS 142.8K
  • Earning Date
  • ELTX 08-12-2025
  • BRLS 08-13-2025
  • Dividend Yield
  • ELTX N/A
  • BRLS N/A
  • EPS Growth
  • ELTX N/A
  • BRLS N/A
  • EPS
  • ELTX N/A
  • BRLS N/A
  • Revenue
  • ELTX N/A
  • BRLS $26,619,131.00
  • Revenue This Year
  • ELTX N/A
  • BRLS N/A
  • Revenue Next Year
  • ELTX N/A
  • BRLS N/A
  • P/E Ratio
  • ELTX N/A
  • BRLS N/A
  • Revenue Growth
  • ELTX N/A
  • BRLS N/A
  • 52 Week Low
  • ELTX $3.34
  • BRLS $3.00
  • 52 Week High
  • ELTX $9.99
  • BRLS $9.47
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 63.45
  • BRLS 48.52
  • Support Level
  • ELTX $7.76
  • BRLS $4.45
  • Resistance Level
  • ELTX $8.10
  • BRLS $6.26
  • Average True Range (ATR)
  • ELTX 0.60
  • BRLS 0.93
  • MACD
  • ELTX -0.03
  • BRLS 0.10
  • Stochastic Oscillator
  • ELTX 54.76
  • BRLS 36.64

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About BRLS BOREALIS FOODS INC

Borealis Foods Inc is a food technology company that has developed high-quality, affordable, sustainable, and nutritious ready-to-eat meals. It is a mission-driven company committed to utilizing its products to help solve national and global food security and nutrition challenges. Its commitment to nutrition, affordability, and sustainability reflects its goal of positively impacting both human life and the planet. Through the development and launch of its ready-made ramen, featuring 20 grams of complete plant-based protein per serving, Borealis is developing advanced solutions to address global food challenges.

Share on Social Networks: